3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Hemangiosarcoma
1
HER2-positive Metastatic Breast Cancer
1
HER2-Positive Primary Breast Cancer
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
fludarabine
17
Cyclophosphamide
15
Specimen Handling
14
Biopsy
12
fludarabine phosphate
11
Melphalan
10
Cytarabine
10
Busulfan
10
Mycophenolic Acid
9
Whole-Body Irradiation
8
Tacrolimus
8
venetoclax
7
decitabine and cedazuridine drug combination
7
Granulocyte Colony-Stimulating Factor
7
Injections
6
Cyclosporine
6
Stem Cell Transplantation
5
Sirolimus
5
Filgrastim
5
Azacitidine
5
X-Rays
4
Thiotepa
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
CPX-351
4
ruxolitinib
3
Magnetic Resonance Spectroscopy
3
Hematopoietic Stem Cell Transplantation
3
Decitabine
3
treosulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Ado-Trastuzumab Emtansine
×
30 days
×
Clear all
No trials found.